JP6963566B2 - アンケージングステント - Google Patents
アンケージングステント Download PDFInfo
- Publication number
- JP6963566B2 JP6963566B2 JP2018560073A JP2018560073A JP6963566B2 JP 6963566 B2 JP6963566 B2 JP 6963566B2 JP 2018560073 A JP2018560073 A JP 2018560073A JP 2018560073 A JP2018560073 A JP 2018560073A JP 6963566 B2 JP6963566 B2 JP 6963566B2
- Authority
- JP
- Japan
- Prior art keywords
- stent
- scaffold
- degradable
- circumferential
- expansion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000926 separation method Methods 0.000 claims description 845
- 239000000463 material Substances 0.000 claims description 574
- 229910052751 metal Inorganic materials 0.000 claims description 253
- 239000002184 metal Substances 0.000 claims description 250
- 229920000642 polymer Polymers 0.000 claims description 176
- 229910001092 metal group alloy Inorganic materials 0.000 claims description 125
- 230000001070 adhesive effect Effects 0.000 claims description 124
- 239000000853 adhesive Substances 0.000 claims description 121
- 230000004044 response Effects 0.000 claims description 112
- 238000000576 coating method Methods 0.000 claims description 93
- 230000033001 locomotion Effects 0.000 claims description 80
- 238000013461 design Methods 0.000 claims description 77
- 239000011248 coating agent Substances 0.000 claims description 74
- -1 lidaphorolimus Chemical compound 0.000 claims description 70
- 239000003814 drug Substances 0.000 claims description 43
- 238000002955 isolation Methods 0.000 claims description 41
- 229910001220 stainless steel Inorganic materials 0.000 claims description 31
- 229940079593 drug Drugs 0.000 claims description 29
- 230000036961 partial effect Effects 0.000 claims description 28
- 229920002988 biodegradable polymer Polymers 0.000 claims description 27
- 239000004621 biodegradable polymer Substances 0.000 claims description 27
- 229920001651 Cyanoacrylate Polymers 0.000 claims description 24
- 239000010935 stainless steel Substances 0.000 claims description 20
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 19
- 230000000717 retained effect Effects 0.000 claims description 18
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 claims description 16
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 16
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 15
- 229910000684 Cobalt-chrome Inorganic materials 0.000 claims description 11
- 239000010952 cobalt-chrome Substances 0.000 claims description 11
- 229910052697 platinum Inorganic materials 0.000 claims description 10
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 claims description 10
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 10
- 229910000531 Co alloy Inorganic materials 0.000 claims description 9
- 229920001244 Poly(D,L-lactide) Polymers 0.000 claims description 9
- 230000001788 irregular Effects 0.000 claims description 9
- MMAADVOQRITKKL-UHFFFAOYSA-N chromium platinum Chemical compound [Cr].[Pt] MMAADVOQRITKKL-UHFFFAOYSA-N 0.000 claims description 7
- 239000004632 polycaprolactone Substances 0.000 claims description 7
- 239000004793 Polystyrene Substances 0.000 claims description 6
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 claims description 6
- 229920002223 polystyrene Polymers 0.000 claims description 6
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 5
- PXXKQOPKNFECSZ-UHFFFAOYSA-N platinum rhodium Chemical compound [Rh].[Pt] PXXKQOPKNFECSZ-UHFFFAOYSA-N 0.000 claims description 5
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 5
- 229920000052 poly(p-xylylene) Polymers 0.000 claims description 5
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 5
- 229920005569 poly(vinylidene fluoride-co-hexafluoropropylene) Polymers 0.000 claims description 4
- 229920001610 polycaprolactone Polymers 0.000 claims description 4
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 claims description 3
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 229920001490 poly(butyl methacrylate) polymer Polymers 0.000 claims description 3
- 239000011118 polyvinyl acetate Substances 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 2
- 229920001054 Poly(ethylene‐co‐vinyl acetate) Polymers 0.000 claims description 2
- 229920000954 Polyglycolide Polymers 0.000 claims description 2
- 229920001434 poly(D-lactide) Polymers 0.000 claims description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- ZHYGVVKSAGDVDY-QQQXYHJWSA-N 7-o-demethyl cypher Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](O)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 ZHYGVVKSAGDVDY-QQQXYHJWSA-N 0.000 claims 1
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 claims 1
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 1
- 210000001520 comb Anatomy 0.000 claims 1
- 229960005167 everolimus Drugs 0.000 claims 1
- 229920001306 poly(lactide-co-caprolactone) Polymers 0.000 claims 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims 1
- 229960002930 sirolimus Drugs 0.000 claims 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 1
- 229960000235 temsirolimus Drugs 0.000 claims 1
- QFJCIRLUMZQUOT-UHFFFAOYSA-N temsirolimus Natural products C1CC(O)C(OC)CC1CC(C)C1OC(=O)C2CCCCN2C(=O)C(=O)C(O)(O2)C(C)CCC2CC(OC)C(C)=CC=CC=CC(C)CC(C)C(=O)C(OC)C(O)C(C)=CC(C)C(=O)C1 QFJCIRLUMZQUOT-UHFFFAOYSA-N 0.000 claims 1
- YYSFXUWWPNHNAZ-PKJQJFMNSA-N umirolimus Chemical compound C1[C@@H](OC)[C@H](OCCOCC)CC[C@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 YYSFXUWWPNHNAZ-PKJQJFMNSA-N 0.000 claims 1
- CGTADGCBEXYWNE-JUKNQOCSSA-N zotarolimus Chemical compound N1([C@H]2CC[C@@H](C[C@@H](C)[C@H]3OC(=O)[C@@H]4CCCCN4C(=O)C(=O)[C@@]4(O)[C@H](C)CC[C@H](O4)C[C@@H](/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C3)OC)C[C@H]2OC)C=NN=N1 CGTADGCBEXYWNE-JUKNQOCSSA-N 0.000 claims 1
- 229950009819 zotarolimus Drugs 0.000 claims 1
- 230000003014 reinforcing effect Effects 0.000 description 293
- 238000006073 displacement reaction Methods 0.000 description 183
- 238000002513 implantation Methods 0.000 description 162
- 230000004962 physiological condition Effects 0.000 description 160
- 230000010339 dilation Effects 0.000 description 159
- 238000012360 testing method Methods 0.000 description 128
- 239000000956 alloy Substances 0.000 description 122
- 230000015572 biosynthetic process Effects 0.000 description 115
- 229910045601 alloy Inorganic materials 0.000 description 111
- 230000002792 vascular Effects 0.000 description 110
- 210000004204 blood vessel Anatomy 0.000 description 93
- 210000004027 cell Anatomy 0.000 description 84
- 239000007943 implant Substances 0.000 description 82
- 239000002131 composite material Substances 0.000 description 74
- 230000008602 contraction Effects 0.000 description 74
- 238000004132 cross linking Methods 0.000 description 69
- 150000002739 metals Chemical class 0.000 description 60
- 230000002829 reductive effect Effects 0.000 description 56
- 230000007423 decrease Effects 0.000 description 53
- 210000001503 joint Anatomy 0.000 description 53
- 238000000034 method Methods 0.000 description 51
- 229920001577 copolymer Polymers 0.000 description 36
- 229940124549 vasodilator Drugs 0.000 description 36
- 239000003071 vasodilator agent Substances 0.000 description 36
- 230000024883 vasodilation Effects 0.000 description 35
- 229920006237 degradable polymer Polymers 0.000 description 34
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 33
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 31
- 238000012986 modification Methods 0.000 description 31
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 31
- 239000002861 polymer material Substances 0.000 description 31
- 230000004048 modification Effects 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 230000008859 change Effects 0.000 description 29
- 238000005259 measurement Methods 0.000 description 29
- 239000007769 metal material Substances 0.000 description 29
- 229910000831 Steel Inorganic materials 0.000 description 28
- 238000004519 manufacturing process Methods 0.000 description 28
- 239000000203 mixture Substances 0.000 description 28
- 239000012779 reinforcing material Substances 0.000 description 28
- 239000010959 steel Substances 0.000 description 28
- 238000000354 decomposition reaction Methods 0.000 description 27
- 238000000059 patterning Methods 0.000 description 25
- 229910000679 solder Inorganic materials 0.000 description 25
- 239000004417 polycarbonate Substances 0.000 description 24
- 229920000515 polycarbonate Polymers 0.000 description 24
- 210000001519 tissue Anatomy 0.000 description 24
- 230000002787 reinforcement Effects 0.000 description 23
- 239000004568 cement Substances 0.000 description 22
- 230000004087 circulation Effects 0.000 description 22
- 238000007634 remodeling Methods 0.000 description 22
- 206010047139 Vasoconstriction Diseases 0.000 description 21
- 239000002253 acid Substances 0.000 description 21
- 150000008064 anhydrides Chemical class 0.000 description 21
- 238000009661 fatigue test Methods 0.000 description 21
- 230000025033 vasoconstriction Effects 0.000 description 21
- 230000027455 binding Effects 0.000 description 20
- 238000009739 binding Methods 0.000 description 20
- 238000002788 crimping Methods 0.000 description 19
- 239000010410 layer Substances 0.000 description 19
- 230000003205 diastolic effect Effects 0.000 description 18
- 238000005520 cutting process Methods 0.000 description 17
- 239000013013 elastic material Substances 0.000 description 17
- 230000001457 vasomotor Effects 0.000 description 17
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 16
- 229910000861 Mg alloy Inorganic materials 0.000 description 16
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 16
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 16
- 229910052742 iron Inorganic materials 0.000 description 16
- 238000012545 processing Methods 0.000 description 16
- 230000010349 pulsation Effects 0.000 description 16
- 239000011701 zinc Substances 0.000 description 16
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 15
- 230000035487 diastolic blood pressure Effects 0.000 description 15
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 15
- 239000010931 gold Substances 0.000 description 15
- 238000000338 in vitro Methods 0.000 description 15
- 239000003550 marker Substances 0.000 description 15
- 229920000058 polyacrylate Polymers 0.000 description 15
- 229920002635 polyurethane Polymers 0.000 description 15
- 239000004814 polyurethane Substances 0.000 description 15
- 230000035488 systolic blood pressure Effects 0.000 description 15
- 229910052718 tin Inorganic materials 0.000 description 15
- 229910052725 zinc Inorganic materials 0.000 description 15
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 14
- 229920001710 Polyorthoester Polymers 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 14
- 229910052737 gold Inorganic materials 0.000 description 14
- 238000005304 joining Methods 0.000 description 14
- 229940124597 therapeutic agent Drugs 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 14
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 14
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 13
- 229920000728 polyester Polymers 0.000 description 13
- 239000003351 stiffener Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 150000003668 tyrosines Chemical class 0.000 description 13
- 229910001182 Mo alloy Inorganic materials 0.000 description 12
- 230000008901 benefit Effects 0.000 description 12
- 102000016942 Elastin Human genes 0.000 description 11
- 108010014258 Elastin Proteins 0.000 description 11
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 11
- 210000001367 artery Anatomy 0.000 description 11
- 230000008878 coupling Effects 0.000 description 11
- 238000010168 coupling process Methods 0.000 description 11
- 238000005859 coupling reaction Methods 0.000 description 11
- 229920002549 elastin Polymers 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000035876 healing Effects 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 229910052749 magnesium Inorganic materials 0.000 description 11
- 239000011777 magnesium Substances 0.000 description 11
- 230000008439 repair process Effects 0.000 description 11
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 11
- 238000004804 winding Methods 0.000 description 11
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 10
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 10
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 10
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 229910017052 cobalt Inorganic materials 0.000 description 10
- 239000010941 cobalt Substances 0.000 description 10
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 10
- 239000010949 copper Substances 0.000 description 10
- 230000001747 exhibiting effect Effects 0.000 description 10
- 229910052750 molybdenum Inorganic materials 0.000 description 10
- 239000011733 molybdenum Substances 0.000 description 10
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 229910052721 tungsten Inorganic materials 0.000 description 10
- 239000010937 tungsten Substances 0.000 description 10
- 229910001226 L605 Inorganic materials 0.000 description 9
- 230000036760 body temperature Effects 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 229910052802 copper Inorganic materials 0.000 description 9
- 230000007797 corrosion Effects 0.000 description 9
- 238000005260 corrosion Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229920001971 elastomer Polymers 0.000 description 9
- 239000003292 glue Substances 0.000 description 9
- 206010020718 hyperplasia Diseases 0.000 description 9
- 239000002745 poly(ortho ester) Substances 0.000 description 9
- 230000033764 rhythmic process Effects 0.000 description 9
- 206010061218 Inflammation Diseases 0.000 description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 8
- 229910001080 W alloy Inorganic materials 0.000 description 8
- 238000010276 construction Methods 0.000 description 8
- 230000003628 erosive effect Effects 0.000 description 8
- 229910052738 indium Inorganic materials 0.000 description 8
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 8
- 230000004054 inflammatory process Effects 0.000 description 8
- 229910052763 palladium Inorganic materials 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 229910052703 rhodium Inorganic materials 0.000 description 8
- 239000010948 rhodium Substances 0.000 description 8
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 8
- 229910052709 silver Inorganic materials 0.000 description 8
- 239000004332 silver Substances 0.000 description 8
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 8
- 239000005526 vasoconstrictor agent Substances 0.000 description 8
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 7
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 7
- 102000009123 Fibrin Human genes 0.000 description 7
- 108010073385 Fibrin Proteins 0.000 description 7
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 7
- 239000002033 PVDF binder Substances 0.000 description 7
- 229920000805 Polyaspartic acid Polymers 0.000 description 7
- 239000004721 Polyphenylene oxide Chemical class 0.000 description 7
- 125000001931 aliphatic group Chemical group 0.000 description 7
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 7
- 239000000806 elastomer Substances 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Substances OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- 229950003499 fibrin Drugs 0.000 description 7
- 230000004927 fusion Effects 0.000 description 7
- 238000009434 installation Methods 0.000 description 7
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 7
- 239000011976 maleic acid Substances 0.000 description 7
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 7
- 238000000465 moulding Methods 0.000 description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 7
- 229920000117 poly(dioxanone) Polymers 0.000 description 7
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 7
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 7
- 229920002627 poly(phosphazenes) Polymers 0.000 description 7
- 108010064470 polyaspartate Proteins 0.000 description 7
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 7
- 229920000570 polyether Chemical class 0.000 description 7
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 7
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 7
- 238000005507 spraying Methods 0.000 description 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 7
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 7
- 208000029497 Elastoma Diseases 0.000 description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- 229910001209 Low-carbon steel Inorganic materials 0.000 description 6
- 229910000990 Ni alloy Inorganic materials 0.000 description 6
- 229920002292 Nylon 6 Polymers 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 229910052797 bismuth Inorganic materials 0.000 description 6
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 6
- 239000000788 chromium alloy Substances 0.000 description 6
- 230000006835 compression Effects 0.000 description 6
- 238000007906 compression Methods 0.000 description 6
- 229960001577 dantron Drugs 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 150000002596 lactones Chemical class 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 229920000071 poly(4-hydroxybutyrate) Polymers 0.000 description 6
- 229920000070 poly-3-hydroxybutyrate Polymers 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 238000005204 segregation Methods 0.000 description 6
- 230000000472 traumatic effect Effects 0.000 description 6
- 229920001661 Chitosan Polymers 0.000 description 5
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 5
- 238000005452 bending Methods 0.000 description 5
- 238000006065 biodegradation reaction Methods 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 238000007598 dipping method Methods 0.000 description 5
- 239000013536 elastomeric material Substances 0.000 description 5
- 239000000945 filler Substances 0.000 description 5
- 238000003698 laser cutting Methods 0.000 description 5
- 229910052759 nickel Inorganic materials 0.000 description 5
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 5
- 230000009972 noncorrosive effect Effects 0.000 description 5
- 239000004926 polymethyl methacrylate Substances 0.000 description 5
- 239000004800 polyvinyl chloride Substances 0.000 description 5
- 229920000915 polyvinyl chloride Polymers 0.000 description 5
- 230000004043 responsiveness Effects 0.000 description 5
- 239000012781 shape memory material Substances 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- DISRGUXSEDBDDN-OAHLLOKOSA-N 6-[6-(methoxymethyl)pyridin-3-yl]-4-[[(1R)-1-(oxan-4-yl)ethyl]amino]quinoline-3-carboxamide Chemical compound COCC1=CC=C(C=N1)C=1C=C2C(=C(C=NC2=CC=1)C(=O)N)N[C@H](C)C1CCOCC1 DISRGUXSEDBDDN-OAHLLOKOSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 229920004943 Delrin® Polymers 0.000 description 4
- 229910001141 Ductile iron Inorganic materials 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 102000003886 Glycoproteins Human genes 0.000 description 4
- 108090000288 Glycoproteins Proteins 0.000 description 4
- 229910000934 Monel 400 Inorganic materials 0.000 description 4
- 229920002614 Polyether block amide Polymers 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 229910001260 Pt alloy Inorganic materials 0.000 description 4
- 229910001128 Sn alloy Inorganic materials 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 208000032594 Vascular Remodeling Diseases 0.000 description 4
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 4
- 229910001297 Zn alloy Inorganic materials 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000004873 anchoring Methods 0.000 description 4
- 230000004323 axial length Effects 0.000 description 4
- OGSYQYXYGXIQFH-UHFFFAOYSA-N chromium molybdenum nickel Chemical compound [Cr].[Ni].[Mo] OGSYQYXYGXIQFH-UHFFFAOYSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- OANFWJQPUHQWDL-UHFFFAOYSA-N copper iron manganese nickel Chemical compound [Mn].[Fe].[Ni].[Cu] OANFWJQPUHQWDL-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000000593 degrading effect Effects 0.000 description 4
- 230000002542 deteriorative effect Effects 0.000 description 4
- 229910003460 diamond Inorganic materials 0.000 description 4
- 239000010432 diamond Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 4
- 229940099552 hyaluronan Drugs 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 229910001119 inconels 625 Inorganic materials 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- DDTIGTPWGISMKL-UHFFFAOYSA-N molybdenum nickel Chemical compound [Ni].[Mo] DDTIGTPWGISMKL-UHFFFAOYSA-N 0.000 description 4
- 230000000149 penetrating effect Effects 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920002647 polyamide Polymers 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 229920001855 polyketal Polymers 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 108010000222 polyserine Proteins 0.000 description 4
- 238000004382 potting Methods 0.000 description 4
- 238000007639 printing Methods 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- 238000005476 soldering Methods 0.000 description 4
- 229910052715 tantalum Inorganic materials 0.000 description 4
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- 210000005166 vasculature Anatomy 0.000 description 4
- 229910052726 zirconium Inorganic materials 0.000 description 4
- 229910000619 316 stainless steel Inorganic materials 0.000 description 3
- 238000010146 3D printing Methods 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 229910001316 Ag alloy Inorganic materials 0.000 description 3
- 229910000838 Al alloy Inorganic materials 0.000 description 3
- 229910000851 Alloy steel Inorganic materials 0.000 description 3
- 229910001020 Au alloy Inorganic materials 0.000 description 3
- 229910017535 Cu-Al-Ni Inorganic materials 0.000 description 3
- 229910017773 Cu-Zn-Al Inorganic materials 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 229910000640 Fe alloy Inorganic materials 0.000 description 3
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 3
- 241000282575 Gorilla Species 0.000 description 3
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 3
- 229910018643 Mn—Si Inorganic materials 0.000 description 3
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 3
- 239000000006 Nitroglycerin Substances 0.000 description 3
- 229920000299 Nylon 12 Polymers 0.000 description 3
- 229920002302 Nylon 6,6 Polymers 0.000 description 3
- 239000004696 Poly ether ether ketone Substances 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 239000004695 Polyether sulfone Substances 0.000 description 3
- 239000004697 Polyetherimide Substances 0.000 description 3
- 229910001114 SAF 2507 Inorganic materials 0.000 description 3
- 229910007116 SnPb Inorganic materials 0.000 description 3
- 229910000883 Ti6Al4V Inorganic materials 0.000 description 3
- 229910001093 Zr alloy Inorganic materials 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000002998 adhesive polymer Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- PRQRQKBNBXPISG-UHFFFAOYSA-N chromium cobalt molybdenum nickel Chemical compound [Cr].[Co].[Ni].[Mo] PRQRQKBNBXPISG-UHFFFAOYSA-N 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000003467 diminishing effect Effects 0.000 description 3
- 210000003017 ductus arteriosus Anatomy 0.000 description 3
- 239000008393 encapsulating agent Substances 0.000 description 3
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 229960003711 glyceryl trinitrate Drugs 0.000 description 3
- 229920001903 high density polyethylene Polymers 0.000 description 3
- 239000004700 high-density polyethylene Substances 0.000 description 3
- 239000011796 hollow space material Substances 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 229920001684 low density polyethylene Polymers 0.000 description 3
- 239000004702 low-density polyethylene Substances 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 238000012014 optical coherence tomography Methods 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 229920009441 perflouroethylene propylene Polymers 0.000 description 3
- 229920011301 perfluoro alkoxyl alkane Polymers 0.000 description 3
- 229920002492 poly(sulfone) Polymers 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 229920006260 polyaryletherketone Polymers 0.000 description 3
- 229920006393 polyether sulfone Polymers 0.000 description 3
- 229920002530 polyetherether ketone Polymers 0.000 description 3
- 229920001601 polyetherimide Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 3
- 239000000565 sealant Substances 0.000 description 3
- 229920000431 shape-memory polymer Polymers 0.000 description 3
- 210000000225 synapse Anatomy 0.000 description 3
- MAKDTFFYCIMFQP-UHFFFAOYSA-N titanium tungsten Chemical compound [Ti].[W] MAKDTFFYCIMFQP-UHFFFAOYSA-N 0.000 description 3
- 210000000591 tricuspid valve Anatomy 0.000 description 3
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- 229910052727 yttrium Inorganic materials 0.000 description 3
- CQVWXNBVRLKXPE-UHFFFAOYSA-N 2-octyl cyanoacrylate Chemical compound CCCCCCC(C)OC(=O)C(=C)C#N CQVWXNBVRLKXPE-UHFFFAOYSA-N 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- 229910001313 Cobalt-iron alloy Inorganic materials 0.000 description 2
- 229910000599 Cr alloy Inorganic materials 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 229910000846 In alloy Inorganic materials 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004813 Perfluoroalkoxy alkane Substances 0.000 description 2
- 229910000566 Platinum-iridium alloy Inorganic materials 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 229920000491 Polyphenylsulfone Polymers 0.000 description 2
- 108010076039 Polyproteins Proteins 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229910001069 Ti alloy Inorganic materials 0.000 description 2
- 229920004738 ULTEM® Polymers 0.000 description 2
- QCEUXSAXTBNJGO-UHFFFAOYSA-N [Ag].[Sn] Chemical compound [Ag].[Sn] QCEUXSAXTBNJGO-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 229920006397 acrylic thermoplastic Polymers 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 210000001765 aortic valve Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 230000026058 directional locomotion Effects 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- JJJFUHOGVZWXNQ-UHFFFAOYSA-N enbucrilate Chemical compound CCCCOC(=O)C(=C)C#N JJJFUHOGVZWXNQ-UHFFFAOYSA-N 0.000 description 2
- 239000003353 gold alloy Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000009191 jumping Effects 0.000 description 2
- LQBJWKCYZGMFEV-UHFFFAOYSA-N lead tin Chemical compound [Sn].[Pb] LQBJWKCYZGMFEV-UHFFFAOYSA-N 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000004115 mitral valve Anatomy 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000000424 optical density measurement Methods 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920001568 phenolic resin Polymers 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920001084 poly(chloroprene) Polymers 0.000 description 2
- 229920001225 polyester resin Polymers 0.000 description 2
- 239000004645 polyester resin Substances 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 229920002959 polymer blend Polymers 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229910052761 rare earth metal Inorganic materials 0.000 description 2
- 150000002910 rare earth metals Chemical class 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 229910052706 scandium Inorganic materials 0.000 description 2
- SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000003894 surgical glue Substances 0.000 description 2
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000000304 vasodilatating effect Effects 0.000 description 2
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 2
- GEUXSIQINMZMEL-QMMMGPOBSA-N (2S)-2-amino-3-(4-hydroxyphenyl)propanoyl iodide Chemical compound IC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GEUXSIQINMZMEL-QMMMGPOBSA-N 0.000 description 1
- ICGQLNMKJVHCIR-UHFFFAOYSA-N 1,3,2-dioxazetidin-4-one Chemical compound O=C1ONO1 ICGQLNMKJVHCIR-UHFFFAOYSA-N 0.000 description 1
- ZVYSYCLZXICWLH-UHFFFAOYSA-N 1,3-dioxetan-2-one Chemical compound O=C1OCO1 ZVYSYCLZXICWLH-UHFFFAOYSA-N 0.000 description 1
- IYPUCXCSXNMZHP-UHFFFAOYSA-N 2-(cyanomethylidene)decanoic acid Chemical class CCCCCCCCC(C(O)=O)=CC#N IYPUCXCSXNMZHP-UHFFFAOYSA-N 0.000 description 1
- BEXLXSRWUSGOOV-UHFFFAOYSA-N 2-cyanohept-2-enoic acid Chemical class CCCCC=C(C#N)C(O)=O BEXLXSRWUSGOOV-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 1
- 239000010963 304 stainless steel Substances 0.000 description 1
- DSUFPYCILZXJFF-UHFFFAOYSA-N 4-[[4-[[4-(pentoxycarbonylamino)cyclohexyl]methyl]cyclohexyl]carbamoyloxy]butyl n-[4-[[4-(butoxycarbonylamino)cyclohexyl]methyl]cyclohexyl]carbamate Chemical compound C1CC(NC(=O)OCCCCC)CCC1CC1CCC(NC(=O)OCCCCOC(=O)NC2CCC(CC3CCC(CC3)NC(=O)OCCCC)CC2)CC1 DSUFPYCILZXJFF-UHFFFAOYSA-N 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 229910000881 Cu alloy Inorganic materials 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 229910001030 Iron–nickel alloy Inorganic materials 0.000 description 1
- 208000034827 Neointima Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 241000209094 Oryza Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- 206010038563 Reocclusion Diseases 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- 229910000589 SAE 304 stainless steel Inorganic materials 0.000 description 1
- 229910001362 Ta alloys Inorganic materials 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 206010070995 Vascular compression Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- PPKXEPBICJTCRU-UHFFFAOYSA-N [2-hydroxy-2-(3-methoxyphenyl)cyclohexyl]methyl-dimethylazanium;chloride Chemical compound Cl.COC1=CC=CC(C2(O)C(CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-UHFFFAOYSA-N 0.000 description 1
- QXZUUHYBWMWJHK-UHFFFAOYSA-N [Co].[Ni] Chemical compound [Co].[Ni] QXZUUHYBWMWJHK-UHFFFAOYSA-N 0.000 description 1
- PSMFTUMUGZHOOU-UHFFFAOYSA-N [In].[Sn].[Bi] Chemical compound [In].[Sn].[Bi] PSMFTUMUGZHOOU-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940089482 combination collagen Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012669 compression test Methods 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 210000003748 coronary sinus Anatomy 0.000 description 1
- 229920006238 degradable plastic Polymers 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- KZTYYGOKRVBIMI-UHFFFAOYSA-N diphenyl sulfone Chemical compound C=1C=CC=CC=1S(=O)(=O)C1=CC=CC=C1 KZTYYGOKRVBIMI-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229950010048 enbucrilate Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- BXOUVIIITJXIKB-UHFFFAOYSA-N ethene;styrene Chemical group C=C.C=CC1=CC=CC=C1 BXOUVIIITJXIKB-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- SLGWESQGEUXWJQ-UHFFFAOYSA-N formaldehyde;phenol Chemical compound O=C.OC1=CC=CC=C1 SLGWESQGEUXWJQ-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229940090044 injection Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002608 intravascular ultrasound Methods 0.000 description 1
- UGKDIUIOSMUOAW-UHFFFAOYSA-N iron nickel Chemical compound [Fe].[Ni] UGKDIUIOSMUOAW-UHFFFAOYSA-N 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 108010004563 mussel adhesive protein Proteins 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000129 polyhexylmethacrylate Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920002742 polystyrene-block-poly(ethylene/propylene) -block-polystyrene Polymers 0.000 description 1
- 229920005996 polystyrene-poly(ethylene-butylene)-polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000013680 response to muscle activity involved in regulation of muscle adaptation Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229920001935 styrene-ethylene-butadiene-styrene Polymers 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 210000001782 transverse sinus Anatomy 0.000 description 1
- 238000009785 tube rolling Methods 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 229940054370 ultram Drugs 0.000 description 1
- 230000004865 vascular response Effects 0.000 description 1
- 230000000283 vasomotion Effects 0.000 description 1
- 210000002073 venous valve Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/825—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having longitudinal struts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91566—Adjacent bands being connected to each other connected trough to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91591—Locking connectors, e.g. using male-female connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0033—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0091—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements connected by a hinged linkage mechanism, e.g. of the single-bar or multi-bar linkage type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0008—Rounded shapes, e.g. with rounded corners elliptical or oval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/001—Figure-8-shaped, e.g. hourglass-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
- A61F2250/0031—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0036—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0048—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0071—Additional features; Implant or prostheses properties not otherwise provided for breakable or frangible
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021039952A JP7478110B2 (ja) | 2016-05-16 | 2021-03-12 | アンケージングステント |
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662337255P | 2016-05-16 | 2016-05-16 | |
| US62/337,255 | 2016-05-16 | ||
| US201662374689P | 2016-08-12 | 2016-08-12 | |
| US62/374,689 | 2016-08-12 | ||
| US201662414593P | 2016-10-28 | 2016-10-28 | |
| US62/414,593 | 2016-10-28 | ||
| US201662424994P | 2016-11-21 | 2016-11-21 | |
| US62/424,994 | 2016-11-21 | ||
| US201662430843P | 2016-12-06 | 2016-12-06 | |
| US62/430,843 | 2016-12-06 | ||
| US201762480121P | 2017-03-31 | 2017-03-31 | |
| US62/480,121 | 2017-03-31 | ||
| PCT/US2017/032748 WO2017200956A1 (en) | 2016-05-16 | 2017-05-15 | Uncaging stent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021039952A Division JP7478110B2 (ja) | 2016-05-16 | 2021-03-12 | アンケージングステント |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019520116A JP2019520116A (ja) | 2019-07-18 |
| JP2019520116A5 JP2019520116A5 (enExample) | 2020-11-19 |
| JP6963566B2 true JP6963566B2 (ja) | 2021-11-10 |
Family
ID=60325521
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560073A Active JP6963566B2 (ja) | 2016-05-16 | 2017-05-15 | アンケージングステント |
| JP2021039952A Active JP7478110B2 (ja) | 2016-05-16 | 2021-03-12 | アンケージングステント |
| JP2021179301A Active JP7029019B2 (ja) | 2016-05-16 | 2021-11-02 | アンケージングステント |
| JP2022051468A Active JP7586848B2 (ja) | 2016-05-16 | 2022-03-28 | アンケージングステント |
| JP2023169649A Pending JP2023165987A (ja) | 2016-05-16 | 2023-09-29 | アンケージングステント |
| JP2025011857A Pending JP2025062612A (ja) | 2016-05-16 | 2025-01-28 | アンケージングステント |
| JP2025139627A Pending JP2025172814A (ja) | 2016-05-16 | 2025-08-25 | アンケージングステント |
Family Applications After (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021039952A Active JP7478110B2 (ja) | 2016-05-16 | 2021-03-12 | アンケージングステント |
| JP2021179301A Active JP7029019B2 (ja) | 2016-05-16 | 2021-11-02 | アンケージングステント |
| JP2022051468A Active JP7586848B2 (ja) | 2016-05-16 | 2022-03-28 | アンケージングステント |
| JP2023169649A Pending JP2023165987A (ja) | 2016-05-16 | 2023-09-29 | アンケージングステント |
| JP2025011857A Pending JP2025062612A (ja) | 2016-05-16 | 2025-01-28 | アンケージングステント |
| JP2025139627A Pending JP2025172814A (ja) | 2016-05-16 | 2025-08-25 | アンケージングステント |
Country Status (6)
| Country | Link |
|---|---|
| US (5) | US9943426B2 (enExample) |
| EP (2) | EP3861961B1 (enExample) |
| JP (7) | JP6963566B2 (enExample) |
| CN (2) | CN113143536B (enExample) |
| ES (1) | ES2873887T3 (enExample) |
| WO (1) | WO2017200956A1 (enExample) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
| US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
| US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
| US10561509B2 (en) | 2013-03-13 | 2020-02-18 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
| US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
| US10206796B2 (en) | 2014-08-27 | 2019-02-19 | DePuy Synthes Products, Inc. | Multi-strand implant with enhanced radiopacity |
| WO2018031714A1 (en) | 2016-08-11 | 2018-02-15 | Foundry Innovation & Research 1, Ltd. | Systems and methods for patient fluid management |
| US12465324B2 (en) | 2015-02-12 | 2025-11-11 | Foundry Innovation & Research 1, Ltd. | Patient fluid management systems and methods employing integrated fluid status sensing |
| US10631984B2 (en) | 2015-12-15 | 2020-04-28 | Neovasc Tiara Inc. | Transseptal delivery system |
| US10143573B2 (en) * | 2015-12-17 | 2018-12-04 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds having flexible distal end |
| CA3007670C (en) | 2016-01-29 | 2024-09-17 | Neovasc Tiara Inc. | PROSTHETIC VALVE PREVENTING OBSTRUCTION THAT WOULD PREVENT FLOW |
| JP6607586B2 (ja) * | 2016-02-16 | 2019-11-20 | 株式会社Pentas | ステント |
| JP6558843B2 (ja) * | 2016-02-25 | 2019-08-14 | 株式会社Pentas | ステント |
| JP2017164323A (ja) * | 2016-03-16 | 2017-09-21 | テルモ株式会社 | ステント |
| EP3861961B1 (en) | 2016-05-16 | 2025-11-12 | Elixir Medical Corporation | Uncaging stent |
| US11622872B2 (en) | 2016-05-16 | 2023-04-11 | Elixir Medical Corporation | Uncaging stent |
| US11206992B2 (en) | 2016-08-11 | 2021-12-28 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
| US11701018B2 (en) * | 2016-08-11 | 2023-07-18 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
| US10076428B2 (en) | 2016-08-25 | 2018-09-18 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
| US10292851B2 (en) | 2016-09-30 | 2019-05-21 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
| US10182927B2 (en) * | 2016-10-21 | 2019-01-22 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
| AU2017361296B2 (en) | 2016-11-21 | 2022-09-29 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
| USD854172S1 (en) * | 2016-12-31 | 2019-07-16 | Woori Material Inc. | Cast |
| JP6953034B2 (ja) * | 2017-03-08 | 2021-10-27 | 国立大学法人山口大学 | 双安定構造を持つ管腔臓器への留置器具 |
| WO2018220146A1 (en) | 2017-05-31 | 2018-12-06 | Foundry Innovation & Research 1, Ltd. | Implantable sensors for vascular monitoring |
| WO2018220143A1 (en) | 2017-05-31 | 2018-12-06 | Foundry Innovation And Research 1, Ltd | Implantable ultrasonic vascular sensor |
| US10842654B2 (en) * | 2017-07-19 | 2020-11-24 | Cook Medical Technologies Llc | Stent with segments capable of uncoupling during expansion |
| CN111212617B (zh) * | 2017-08-11 | 2022-06-03 | 万能医药公司 | 撑开支架 |
| US10806564B2 (en) * | 2017-08-23 | 2020-10-20 | Asahi Kasei Kabushiki Kaisha | Catheter systems and methods of treating a vascular disease using the same |
| WO2019036810A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | TRANSCATHETER MITRAL VALVULE PROSTHESIS WITH SEQUENTIAL DEPLOYMENT |
| US10271977B2 (en) | 2017-09-08 | 2019-04-30 | Vesper Medical, Inc. | Hybrid stent |
| US11357650B2 (en) * | 2019-02-28 | 2022-06-14 | Vesper Medical, Inc. | Hybrid stent |
| US11628076B2 (en) | 2017-09-08 | 2023-04-18 | Vesper Medical, Inc. | Hybrid stent |
| US10500078B2 (en) | 2018-03-09 | 2019-12-10 | Vesper Medical, Inc. | Implantable stent |
| KR102857889B1 (ko) * | 2018-05-30 | 2025-09-09 | 파운드리 이노베이션 앤드 리서치 1 리미티드 | 무선 공진 회로와 가변 인덕턴스 혈관 모니터링 이식체와 그를 위한 정착 구조 |
| AU2019204522A1 (en) | 2018-07-30 | 2020-02-13 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
| US10278848B1 (en) | 2018-08-06 | 2019-05-07 | DePuy Synthes Products, Inc. | Stent delivery with expansion assisting delivery wire |
| US10456280B1 (en) | 2018-08-06 | 2019-10-29 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
| AU2019374743B2 (en) | 2018-11-08 | 2022-03-03 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
| CN113329716A (zh) * | 2018-11-16 | 2021-08-31 | 微仙美国有限公司 | 不透射线的血管假体 |
| US11925570B2 (en) | 2018-12-19 | 2024-03-12 | Boston Scientific Scimed, Inc. | Stent including anti-migration capabilities |
| US11039944B2 (en) | 2018-12-27 | 2021-06-22 | DePuy Synthes Products, Inc. | Braided stent system with one or more expansion rings |
| EP3934591A4 (en) | 2019-03-08 | 2022-11-23 | Neovasc Tiara Inc. | RETRIEVABLE PROSTHETIC RELEASE SYSTEM |
| EP3714914A1 (en) * | 2019-03-29 | 2020-09-30 | Picosun Oy | Spring loaded medical device |
| EP3946163B1 (en) | 2019-04-01 | 2025-08-20 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
| AU2020271896B2 (en) | 2019-04-10 | 2022-10-13 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
| DE102019112971A1 (de) * | 2019-05-16 | 2020-11-19 | Optimed Medizinische Instrumente Gmbh | Stent |
| CN114025813B (zh) | 2019-05-20 | 2024-05-14 | 内奥瓦斯克迪亚拉公司 | 具有止血机构的引入器 |
| AU2020295566B2 (en) | 2019-06-20 | 2023-07-20 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
| JP2022540692A (ja) * | 2019-07-19 | 2022-09-16 | エリクシアー メディカル コーポレイション | 血栓の吸引のためのデバイスおよび方法 |
| CN110433016A (zh) * | 2019-08-08 | 2019-11-12 | 郑州铁路职业技术学院 | 直型肠胃用消化道支架 |
| JP6967571B2 (ja) | 2019-11-15 | 2021-11-17 | 株式会社Biomedical Solutions | ステント |
| US12279948B2 (en) * | 2020-02-27 | 2025-04-22 | Cephea Valve Technologies, Inc. | Valve retention supplemented with a wire hoop |
| US20230138256A1 (en) * | 2020-03-12 | 2023-05-04 | Jms Co., Ltd. | Stent |
| US12383246B2 (en) | 2020-10-12 | 2025-08-12 | Abbott Cardiovascular Systems, Inc. | Vessel closure device with improved safety and tract hemostasis |
| KR102532990B1 (ko) * | 2021-01-28 | 2023-05-15 | 경북대학교 산학협력단 | 레이저를 이용한 의료용 스텐트 제조방법 |
| KR102831935B1 (ko) * | 2021-03-23 | 2025-07-10 | 니혼라이프라인 가부시키가이샤 | 스텐트 |
| WO2023028107A1 (en) * | 2021-08-25 | 2023-03-02 | Boston Scientific Scimed, Inc. | Replacement heart valve implant and expandable framework for replacement heart valve implant |
| WO2023192201A1 (en) | 2022-03-28 | 2023-10-05 | Elixir Medical Corporation | Aspiration catheters with expandable distal tip |
| CN114601608B (zh) * | 2022-04-20 | 2025-08-01 | 首都医科大学附属北京天坛医院 | 一种血管支架及支架组件 |
| DE102022111893A1 (de) * | 2022-05-12 | 2023-11-16 | Acandis Gmbh | Medizinische Vorrichtung zur intravaskulären Behandlung und Herstellungsverfahren |
| WO2023250246A2 (en) * | 2022-06-24 | 2023-12-28 | Razmodics Llc | Implantable scaffolds having biodegradable components and methods of manufacturing and use thereof |
| WO2024023791A1 (en) | 2022-07-29 | 2024-02-01 | Foundry Innovation & Research 1, Ltd. | Multistranded conductors adapted to dynamic in vivo environments |
| CN115568989A (zh) * | 2022-10-24 | 2023-01-06 | 上海励楷科技有限公司 | 显影支架 |
| CN115891135B (zh) * | 2022-11-24 | 2024-10-25 | 中国科学院深圳先进技术研究院 | 一种形状记忆复合材料及其制备方法和应用 |
| CN118267204B (zh) * | 2022-12-29 | 2025-12-16 | 先健科技(深圳)有限公司 | 凹槽支架 |
| WO2024194102A1 (en) * | 2023-03-17 | 2024-09-26 | Koninklijke Philips N.V. | Self-locking stent |
| CN116271502B (zh) * | 2023-04-26 | 2024-04-23 | 心擎医疗(苏州)股份有限公司 | 导管泵 |
| US20240374305A1 (en) * | 2023-05-10 | 2024-11-14 | Biosense Webster (Israel) Ltd. | Multi-piece basket catheter comprising hinges |
| CN116919652B (zh) * | 2023-09-18 | 2024-01-19 | 北京心祐医疗科技有限公司 | 可降解滤器 |
Family Cites Families (348)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1027197A (en) | 1912-05-21 | Goodwin Car Company | Drop-door-operating mechanism for dumping-cars. | |
| US1007643A (en) | 1910-09-14 | 1911-10-31 | Frederick Clare | Radiator. |
| US1038375A (en) | 1911-04-17 | 1912-09-10 | Emil Jacobson | Means for heating water. |
| US1607708A (en) | 1924-10-22 | 1926-11-23 | Air Reduction | Separation of the constituents of gaseous mixtures |
| US3867190A (en) | 1971-10-18 | 1975-02-18 | American Cyanamid Co | Reducing capillarity of polyglycolic acid sutures |
| US5059211A (en) | 1987-06-25 | 1991-10-22 | Duke University | Absorbable vascular stent |
| AU7998091A (en) | 1990-05-17 | 1991-12-10 | Harbor Medical Devices, Inc. | Medical device polymer |
| US5298276A (en) | 1990-08-24 | 1994-03-29 | Swaminathan Jayaraman | Process for producing artificial blood vessels of controlled permeability and product produced thereby |
| NL9001984A (nl) | 1990-09-10 | 1992-04-01 | Stamicarbon | Werkwijze voor het produceren van een voorwerp van een copolymeer van lactide en epsilon-caprolacton voor medische toepassingen. |
| CA2060635A1 (en) | 1991-02-12 | 1992-08-13 | Keith D'alessio | Bioabsorbable medical implants |
| US5500013A (en) | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
| EP0554579B1 (de) | 1992-02-03 | 1996-03-27 | Schneider (Europe) Ag | Katheter mit einer Gefässstütze |
| US5683448A (en) | 1992-02-21 | 1997-11-04 | Boston Scientific Technology, Inc. | Intraluminal stent and graft |
| US5449384A (en) | 1992-09-28 | 1995-09-12 | Medtronic, Inc. | Dynamic annulus heart valve employing preserved porcine valve leaflets |
| US5441483A (en) | 1992-11-16 | 1995-08-15 | Avitall; Boaz | Catheter deflection control |
| US5383926A (en) | 1992-11-23 | 1995-01-24 | Children's Medical Center Corporation | Re-expandable endoprosthesis |
| DE69431989T2 (de) | 1993-04-13 | 2003-11-06 | Boston Scientific Corp., Natick | Vorrichtung zum anbringen einer prothese mit einer dilatationsspitze |
| US5441515A (en) | 1993-04-23 | 1995-08-15 | Advanced Cardiovascular Systems, Inc. | Ratcheting stent |
| US5556413A (en) * | 1994-03-11 | 1996-09-17 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
| US5741329A (en) | 1994-12-21 | 1998-04-21 | Board Of Regents, The University Of Texas System | Method of controlling the pH in the vicinity of biodegradable implants |
| US6039755A (en) | 1997-02-05 | 2000-03-21 | Impra, Inc., A Division Of C.R. Bard, Inc. | Radially expandable tubular polytetrafluoroethylene grafts and method of making same |
| US7550005B2 (en) | 1995-06-07 | 2009-06-23 | Cook Incorporated | Coated implantable medical device |
| US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
| US5797951A (en) * | 1995-08-09 | 1998-08-25 | Mueller; Edward Gene | Expandable support member |
| FI98136C (fi) | 1995-09-27 | 1997-04-25 | Biocon Oy | Kudosolosuhteissa hajoava materiaali ja menetelmä sen valmistamiseksi |
| US5741293A (en) | 1995-11-28 | 1998-04-21 | Wijay; Bandula | Locking stent |
| US5843117A (en) | 1996-02-14 | 1998-12-01 | Inflow Dynamics Inc. | Implantable vascular and endoluminal stents and process of fabricating the same |
| US5695516A (en) | 1996-02-21 | 1997-12-09 | Iso Stent, Inc. | Longitudinally elongating balloon expandable stent |
| NZ331269A (en) | 1996-04-10 | 2000-01-28 | Advanced Cardiovascular System | Expandable stent, its structural strength varying along its length |
| US6241760B1 (en) | 1996-04-26 | 2001-06-05 | G. David Jang | Intravascular stent |
| US5670161A (en) | 1996-05-28 | 1997-09-23 | Healy; Kevin E. | Biodegradable stent |
| US5922020A (en) | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
| US20030093143A1 (en) | 1999-03-01 | 2003-05-15 | Yiju Zhao | Medical device having surface depressions containing nitric oxide releasing compound |
| US5868781A (en) * | 1996-10-22 | 1999-02-09 | Scimed Life Systems, Inc. | Locking stent |
| CA2274906A1 (en) | 1996-12-13 | 1998-06-18 | Gregory J. Delmain | Biocompatible medical devices with polyurethane surface |
| US5961545A (en) | 1997-01-17 | 1999-10-05 | Meadox Medicals, Inc. | EPTFE graft-stent composite device |
| US8663311B2 (en) * | 1997-01-24 | 2014-03-04 | Celonova Stent, Inc. | Device comprising biodegradable bistable or multistable cells and methods of use |
| US5911732A (en) | 1997-03-10 | 1999-06-15 | Johnson & Johnson Interventional Systems, Co. | Articulated expandable intraluminal stent |
| US5824053A (en) | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Helical mesh endoprosthesis and methods of use |
| US10028851B2 (en) | 1997-04-15 | 2018-07-24 | Advanced Cardiovascular Systems, Inc. | Coatings for controlling erosion of a substrate of an implantable medical device |
| US5843172A (en) | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
| US8172897B2 (en) | 1997-04-15 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Polymer and metal composite implantable medical devices |
| US6610764B1 (en) | 1997-05-12 | 2003-08-26 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
| DE19722384A1 (de) | 1997-05-28 | 1998-12-03 | Gfe Ges Fuer Forschung Und Ent | Flexible expandierbare Gefäßstütze |
| EP0884029B1 (en) | 1997-06-13 | 2004-12-22 | Gary J. Becker | Expandable intraluminal endoprosthesis |
| CA2241558A1 (en) | 1997-06-24 | 1998-12-24 | Advanced Cardiovascular Systems, Inc. | Stent with reinforced struts and bimodal deployment |
| US5980564A (en) | 1997-08-01 | 1999-11-09 | Schneider (Usa) Inc. | Bioabsorbable implantable endoprosthesis with reservoir |
| US6245103B1 (en) | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
| US5824059A (en) * | 1997-08-05 | 1998-10-20 | Wijay; Bandula | Flexible stent |
| US5935119A (en) | 1997-08-06 | 1999-08-10 | United States Surgical Corporation | Perfusion structure |
| US5957975A (en) | 1997-12-15 | 1999-09-28 | The Cleveland Clinic Foundation | Stent having a programmed pattern of in vivo degradation |
| US5964798A (en) | 1997-12-16 | 1999-10-12 | Cardiovasc, Inc. | Stent having high radial strength |
| US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
| US6623521B2 (en) * | 1998-02-17 | 2003-09-23 | Md3, Inc. | Expandable stent with sliding and locking radial elements |
| US20020038146A1 (en) | 1998-07-29 | 2002-03-28 | Ulf Harry | Expandable stent with relief cuts for carrying medicines and other materials |
| US6547814B2 (en) | 1998-09-30 | 2003-04-15 | Impra, Inc. | Selective adherence of stent-graft coverings |
| US6293967B1 (en) | 1998-10-29 | 2001-09-25 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
| US20050033399A1 (en) * | 1998-12-03 | 2005-02-10 | Jacob Richter | Hybrid stent |
| US6340366B2 (en) * | 1998-12-08 | 2002-01-22 | Bandula Wijay | Stent with nested or overlapping rings |
| US6336937B1 (en) | 1998-12-09 | 2002-01-08 | Gore Enterprise Holdings, Inc. | Multi-stage expandable stent-graft |
| US6120847A (en) | 1999-01-08 | 2000-09-19 | Scimed Life Systems, Inc. | Surface treatment method for stent coating |
| EP1020166A1 (en) | 1999-01-12 | 2000-07-19 | Orbus Medical Technologies, Inc. | Expandable intraluminal endoprosthesis |
| NL1011903C2 (nl) * | 1999-02-05 | 2000-08-08 | Surgical Innovations Vof | Verwijderbare stent. |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6251134B1 (en) | 1999-02-28 | 2001-06-26 | Inflow Dynamics Inc. | Stent with high longitudinal flexibility |
| US6325825B1 (en) | 1999-04-08 | 2001-12-04 | Cordis Corporation | Stent with variable wall thickness |
| US6258117B1 (en) * | 1999-04-15 | 2001-07-10 | Mayo Foundation For Medical Education And Research | Multi-section stent |
| US6224803B1 (en) | 1999-04-28 | 2001-05-01 | Advanced Cardiovascular Systems, Inc. | Method of forming a thin walled member by extrusion and medical device produced thereby |
| US6156373A (en) | 1999-05-03 | 2000-12-05 | Scimed Life Systems, Inc. | Medical device coating methods and devices |
| US6761784B1 (en) | 1999-05-05 | 2004-07-13 | Vision-Ease Lens, Inc. | Temporary protective layer on polymeric articles |
| WO2000067670A1 (en) | 1999-05-07 | 2000-11-16 | Salviac Limited | An embolic protection device |
| US6409754B1 (en) | 1999-07-02 | 2002-06-25 | Scimed Life Systems, Inc. | Flexible segmented stent |
| US6596235B2 (en) | 1999-09-30 | 2003-07-22 | Therox, Inc. | Method for blood oxygenation |
| US6338739B1 (en) | 1999-12-22 | 2002-01-15 | Ethicon, Inc. | Biodegradable stent |
| EP1132058A1 (en) | 2000-03-06 | 2001-09-12 | Advanced Laser Applications Holding S.A. | Intravascular prothesis |
| DE10012460A1 (de) | 2000-03-15 | 2001-09-20 | Biotronik Mess & Therapieg | Stent |
| US20160287708A9 (en) | 2000-03-15 | 2016-10-06 | Orbusneich Medical, Inc. | Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device |
| US6527801B1 (en) | 2000-04-13 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Biodegradable drug delivery material for stent |
| US6602282B1 (en) | 2000-05-04 | 2003-08-05 | Avantec Vascular Corporation | Flexible stent structure |
| US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
| US6395326B1 (en) | 2000-05-31 | 2002-05-28 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for depositing a coating onto a surface of a prosthesis |
| WO2001095834A1 (en) | 2000-06-13 | 2001-12-20 | Scimed Life Systems, Inc. | Disintegrating stent and method of making same |
| US6805898B1 (en) | 2000-09-28 | 2004-10-19 | Advanced Cardiovascular Systems, Inc. | Surface features of an implantable medical device |
| US6764507B2 (en) | 2000-10-16 | 2004-07-20 | Conor Medsystems, Inc. | Expandable medical device with improved spatial distribution |
| US20030050692A1 (en) | 2000-12-22 | 2003-03-13 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
| US20030033007A1 (en) | 2000-12-22 | 2003-02-13 | Avantec Vascular Corporation | Methods and devices for delivery of therapeutic capable agents with variable release profile |
| US6565599B1 (en) * | 2000-12-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Hybrid stent |
| DE10103000B4 (de) * | 2001-01-24 | 2007-08-30 | Qualimed Innovative Medizinprodukte Gmbh | Radial reexpandierbare Gefäßstütze |
| US6964680B2 (en) * | 2001-02-05 | 2005-11-15 | Conor Medsystems, Inc. | Expandable medical device with tapered hinge |
| US20040220660A1 (en) | 2001-02-05 | 2004-11-04 | Shanley John F. | Bioresorbable stent with beneficial agent reservoirs |
| DE10105160B4 (de) | 2001-02-06 | 2005-09-01 | Osypka, Peter, Dr.-Ing. | Implantierbare Gefäßstütze |
| US6540777B2 (en) * | 2001-02-15 | 2003-04-01 | Scimed Life Systems, Inc. | Locking stent |
| US6623518B2 (en) * | 2001-02-26 | 2003-09-23 | Ev3 Peripheral, Inc. | Implant delivery system with interlock |
| WO2002069848A2 (en) | 2001-03-06 | 2002-09-12 | Board Of Regents, The University Of Texas System | Apparatus for stent deployment with delivery of bioactive agents |
| US7048939B2 (en) | 2001-04-20 | 2006-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for the inhibition of neointima formation |
| US6551352B2 (en) | 2001-05-03 | 2003-04-22 | Bionx Implants, Inc. | Method for attaching axial filaments to a self expanding stent |
| BR0103255A (pt) | 2001-05-16 | 2003-05-20 | Christiane Dias Maues | Dispositivo protético tubular cilìndrico; e dispositivo protético com envoltório de capa biológica para liberação de fármacos; e respectivo sistema de delivramento intraluminal |
| US7862495B2 (en) | 2001-05-31 | 2011-01-04 | Advanced Cardiovascular Systems, Inc. | Radiation or drug delivery source with activity gradient to minimize edge effects |
| US6599314B2 (en) | 2001-06-08 | 2003-07-29 | Cordis Corporation | Apparatus and method for stenting a vessel using balloon-actuated stent with interlocking elements |
| US6656216B1 (en) | 2001-06-29 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Composite stent with regioselective material |
| US6585755B2 (en) | 2001-06-29 | 2003-07-01 | Advanced Cardiovascular | Polymeric stent suitable for imaging by MRI and fluoroscopy |
| US20030050687A1 (en) | 2001-07-03 | 2003-03-13 | Schwade Nathan D. | Biocompatible stents and method of deployment |
| CN1131074C (zh) | 2001-08-10 | 2003-12-17 | 中国人民解放军总医院 | 一种用于微创快速血管吻合技术的速溶支架的制备方法 |
| US7285304B1 (en) | 2003-06-25 | 2007-10-23 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
| US6863683B2 (en) * | 2001-09-19 | 2005-03-08 | Abbott Laboratoris Vascular Entities Limited | Cold-molding process for loading a stent onto a stent delivery system |
| EP1304092B1 (en) | 2001-10-22 | 2007-12-05 | Terumo Kabushiki Kaisha | Stent and method of producing the same |
| US7572287B2 (en) | 2001-10-25 | 2009-08-11 | Boston Scientific Scimed, Inc. | Balloon expandable polymer stent with reduced elastic recoil |
| US8740973B2 (en) | 2001-10-26 | 2014-06-03 | Icon Medical Corp. | Polymer biodegradable medical device |
| US20030088307A1 (en) | 2001-11-05 | 2003-05-08 | Shulze John E. | Potent coatings for stents |
| JP2003153639A (ja) | 2001-11-19 | 2003-05-27 | Kao Corp | ペット用トイレ |
| US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
| US20040186551A1 (en) * | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
| US20030135266A1 (en) | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
| US6866805B2 (en) | 2001-12-27 | 2005-03-15 | Advanced Cardiovascular Systems, Inc. | Hybrid intravascular stent |
| US6981985B2 (en) * | 2002-01-22 | 2006-01-03 | Boston Scientific Scimed, Inc. | Stent bumper struts |
| US7029493B2 (en) | 2002-01-25 | 2006-04-18 | Cordis Corporation | Stent with enhanced crossability |
| US7354450B2 (en) | 2002-01-30 | 2008-04-08 | Boston Scientific Scimed, Inc. | Stent with wishbone connectors and serpentine bands |
| ATE362741T1 (de) | 2002-01-31 | 2007-06-15 | Radi Medical Systems | Sich auflösender stent |
| US20030153971A1 (en) | 2002-02-14 | 2003-08-14 | Chandru Chandrasekaran | Metal reinforced biodegradable intraluminal stents |
| US7144420B2 (en) * | 2002-03-14 | 2006-12-05 | Boston Scientific Scimed, Inc. | Segmented spine |
| GB0206061D0 (en) * | 2002-03-14 | 2002-04-24 | Angiomed Ag | Metal structure compatible with MRI imaging, and method of manufacturing such a structure |
| EP1348402A1 (en) | 2002-03-29 | 2003-10-01 | Advanced Laser Applications Holding S.A. | Intraluminal endoprosthesis, radially expandable, perforated for drug delivery |
| US20030195609A1 (en) | 2002-04-10 | 2003-10-16 | Scimed Life Systems, Inc. | Hybrid stent |
| US7261734B2 (en) | 2002-04-23 | 2007-08-28 | Boston Scientific Scimed, Inc. | Resorption-controllable medical implants |
| US7141063B2 (en) * | 2002-08-06 | 2006-11-28 | Icon Medical Corp. | Stent with micro-latching hinge joints |
| US6945995B2 (en) * | 2002-08-29 | 2005-09-20 | Boston Scientific Scimed, Inc. | Stent overlap point markers |
| US7758636B2 (en) | 2002-09-20 | 2010-07-20 | Innovational Holdings Llc | Expandable medical device with openings for delivery of multiple beneficial agents |
| EP1549254A4 (en) | 2002-09-27 | 2007-11-07 | Medlogics Device Corp | IMPLANTABLE STENT WITH MODIFIED ENDS |
| US7223283B2 (en) | 2002-10-09 | 2007-05-29 | Boston Scientific Scimed, Inc. | Stent with improved flexibility |
| US7794494B2 (en) | 2002-10-11 | 2010-09-14 | Boston Scientific Scimed, Inc. | Implantable medical devices |
| JP3988619B2 (ja) | 2002-10-31 | 2007-10-10 | 東レ株式会社 | ポリ乳酸系樹脂組成物およびそれからなる成形品 |
| US20050187615A1 (en) | 2004-02-23 | 2005-08-25 | Williams Michael S. | Polymeric endoprostheses with enhanced strength and flexibility and methods of manufacture |
| US20040111144A1 (en) | 2002-12-06 | 2004-06-10 | Lawin Laurie R. | Barriers for polymeric coatings |
| US6863757B1 (en) | 2002-12-19 | 2005-03-08 | Advanced Cardiovascular Systems, Inc. | Method of making an expandable medical device formed of a compacted porous polymeric material |
| US7455687B2 (en) | 2002-12-30 | 2008-11-25 | Advanced Cardiovascular Systems, Inc. | Polymer link hybrid stent |
| US20040147999A1 (en) | 2003-01-24 | 2004-07-29 | Kishore Udipi | Stent with epoxy primer coating |
| US20040167610A1 (en) * | 2003-02-26 | 2004-08-26 | Fleming James A. | Locking stent |
| US20080051866A1 (en) * | 2003-02-26 | 2008-02-28 | Chao Chin Chen | Drug delivery devices and methods |
| US6920677B2 (en) | 2003-02-27 | 2005-07-26 | Medtronic Vascular, Inc. | Method for manufacturing an endovascular support device |
| US7001421B2 (en) | 2003-02-28 | 2006-02-21 | Medtronic Vascular, Inc. | Stent with phenoxy primer coating |
| US6932930B2 (en) | 2003-03-10 | 2005-08-23 | Synecor, Llc | Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same |
| US20050070996A1 (en) | 2003-04-08 | 2005-03-31 | Dinh Thomas Q. | Drug-eluting stent for controlled drug delivery |
| ATE446061T1 (de) | 2003-04-24 | 2009-11-15 | Cook Inc | Künstliche klappe für blutgefäss mit verbessertem fliessverhalten |
| GB0310300D0 (en) | 2003-05-06 | 2003-06-11 | Univ Belfast | Nanocomposite drug delivery composition |
| US7235093B2 (en) * | 2003-05-20 | 2007-06-26 | Boston Scientific Scimed, Inc. | Mechanism to improve stent securement |
| BRPI0411431B8 (pt) | 2003-06-13 | 2021-06-22 | Gkss Forschungszentrum Geesthacht Gmbh | stents biodegradáveis |
| CA2530032C (en) | 2003-06-16 | 2015-11-24 | Loma Linda University Medical Center | Deployable multifunctional hemostatic agent |
| JP2006527628A (ja) | 2003-06-16 | 2006-12-07 | ナンヤン・テクノロジカル・ユニバーシティー | ポリマー材のステントおよび製造方法 |
| ATE397952T1 (de) | 2003-07-18 | 2008-07-15 | Boston Scient Ltd | Medizinische vorrichtungen |
| US8029755B2 (en) | 2003-08-06 | 2011-10-04 | Angstrom Medica | Tricalcium phosphates, their composites, implants incorporating them, and method for their production |
| US20050060020A1 (en) | 2003-09-17 | 2005-03-17 | Scimed Life Systems, Inc. | Covered stent with biologically active material |
| US7247166B2 (en) | 2003-09-29 | 2007-07-24 | Advanced Cardiovascular Systems, Inc. | Intravascular stent with extendible end rings |
| US20070219613A1 (en) * | 2003-10-06 | 2007-09-20 | Xtent, Inc. | Apparatus and methods for interlocking stent segments |
| US7377939B2 (en) | 2003-11-19 | 2008-05-27 | Synecor, Llc | Highly convertible endolumenal prostheses and methods of manufacture |
| US8157855B2 (en) * | 2003-12-05 | 2012-04-17 | Boston Scientific Scimed, Inc. | Detachable segment stent |
| US7258697B1 (en) | 2003-12-22 | 2007-08-21 | Advanced Cardiovascular Systems, Inc. | Stent with anchors to prevent vulnerable plaque rupture during deployment |
| DE10361940A1 (de) | 2003-12-24 | 2005-07-28 | Restate Patent Ag | Degradationssteuerung biodegradierbarer Implantate durch Beschichtung |
| GB0400571D0 (en) | 2004-01-12 | 2004-02-11 | Angiomed Gmbh & Co | Implant |
| DE102004003093B4 (de) * | 2004-01-21 | 2009-01-29 | Admedes Schuessler Gmbh | Stent zum Einsetzen und Expandieren in einem Lumen |
| US20050182479A1 (en) | 2004-02-13 | 2005-08-18 | Craig Bonsignore | Connector members for stents |
| US20050222671A1 (en) | 2004-03-31 | 2005-10-06 | Schaeffer Darin G | Partially biodegradable stent |
| US7731740B2 (en) | 2004-04-02 | 2010-06-08 | Arterial Remodelling Technologies, Inc. | Polymer-based stent assembly |
| US7709570B2 (en) | 2004-04-02 | 2010-05-04 | Alps South, LLC | Surface modification of triblock copolymer elastomers |
| JP2005298617A (ja) | 2004-04-09 | 2005-10-27 | Mitsubishi Plastics Ind Ltd | 射出成形体 |
| EP1737391A2 (en) | 2004-04-13 | 2007-01-03 | Cook Incorporated | Implantable frame with variable compliance |
| US8007737B2 (en) | 2004-04-14 | 2011-08-30 | Wyeth | Use of antioxidants to prevent oxidation and reduce drug degradation in drug eluting medical devices |
| CN1569270B (zh) | 2004-04-29 | 2011-06-29 | 上海瑞邦生物材料有限公司 | 一种表面设有药物涂层的心血管支架的制备方法 |
| US20050261757A1 (en) | 2004-05-21 | 2005-11-24 | Conor Medsystems, Inc. | Stent with contoured bridging element |
| DE102004027108B4 (de) | 2004-06-03 | 2009-01-22 | Osypka, Peter, Dr. Ing. | Implantierbare Gefäßstütze, die in zumindest zwei Schritten aufweitbar ist |
| US8568469B1 (en) * | 2004-06-28 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Stent locking element and a method of securing a stent on a delivery system |
| US8241554B1 (en) | 2004-06-29 | 2012-08-14 | Advanced Cardiovascular Systems, Inc. | Method of forming a stent pattern on a tube |
| US7763065B2 (en) * | 2004-07-21 | 2010-07-27 | Reva Medical, Inc. | Balloon expandable crush-recoverable stent device |
| US8747878B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device by controlling crystalline structure |
| US8747879B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
| US7731890B2 (en) | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
| US8778256B1 (en) | 2004-09-30 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Deformation of a polymer tube in the fabrication of a medical article |
| US7971333B2 (en) | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
| US8501079B2 (en) | 2009-09-14 | 2013-08-06 | Abbott Cardiovascular Systems Inc. | Controlling crystalline morphology of a bioabsorbable stent |
| US8268228B2 (en) | 2007-12-11 | 2012-09-18 | Abbott Cardiovascular Systems Inc. | Method of fabricating stents from blow molded tubing |
| US20060025852A1 (en) | 2004-08-02 | 2006-02-02 | Armstrong Joseph R | Bioabsorbable self-expanding endolumenal devices |
| US7323008B2 (en) * | 2004-08-09 | 2008-01-29 | Medtronic Vascular, Inc. | Flexible stent |
| US8366762B2 (en) | 2004-08-31 | 2013-02-05 | Advanced Cardiovascular Systems, Inc. | Method of making a medical device with regioselective structure-property distribution |
| US8864820B2 (en) | 2004-08-31 | 2014-10-21 | Advanced Cardiovascular Systems, Inc. | Selective coating of an implantable medical device |
| DE102004045224B4 (de) * | 2004-09-17 | 2010-12-30 | Thilo Dr. Fliedner | Stützprothese |
| US20060069424A1 (en) * | 2004-09-27 | 2006-03-30 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
| US8043553B1 (en) | 2004-09-30 | 2011-10-25 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article |
| US8173062B1 (en) | 2004-09-30 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube in fabricating a medical article |
| US7875233B2 (en) | 2004-09-30 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a biaxially oriented implantable medical device |
| US20060122694A1 (en) | 2004-12-03 | 2006-06-08 | Stinson Jonathan S | Medical devices and methods of making the same |
| US7632307B2 (en) | 2004-12-16 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Abluminal, multilayer coating constructs for drug-delivery stents |
| US8292944B2 (en) | 2004-12-17 | 2012-10-23 | Reva Medical, Inc. | Slide-and-lock stent |
| JP4820551B2 (ja) | 2005-01-14 | 2011-11-24 | テルモ株式会社 | 生体内留置物 |
| JP2008528698A (ja) | 2005-02-03 | 2008-07-31 | インターシア セラピューティクス,インコーポレイティド | 埋め込み可能なインターフェロン含有デバイス |
| US8420113B2 (en) | 2005-02-10 | 2013-04-16 | Cordis Corporation | Biodegradable medical devices with enhanced mechanical strength and pharmacological functions |
| US8002818B2 (en) * | 2005-02-25 | 2011-08-23 | Abbott Laboratories Vascular Enterprises Limited | Modular vascular prosthesis having axially variable properties and improved flexibility and methods of use |
| US8025694B2 (en) * | 2005-02-25 | 2011-09-27 | Abbott Laboratories Vascular Enterprises Limited | Modular vascular prosthesis and methods of use |
| US20070213810A1 (en) * | 2005-03-14 | 2007-09-13 | Richard Newhauser | Segmented endoprosthesis |
| US9056157B2 (en) | 2005-03-24 | 2015-06-16 | Medtronic Vascular, Inc. | Hybrid biodegradable/non-biodegradable stent, delivery system and method of treating a vascular condition |
| WO2006107957A2 (en) | 2005-04-04 | 2006-10-12 | Sinexus, Inc. | Device and methods for treating paranasal sinus conditions |
| JP5312018B2 (ja) | 2005-04-05 | 2013-10-09 | エリクシアー メディカル コーポレイション | 分解性の移植可能な医療装置 |
| US7402168B2 (en) | 2005-04-11 | 2008-07-22 | Xtent, Inc. | Custom-length stent delivery system with independently operable expansion elements |
| EP1903999B1 (en) | 2005-04-25 | 2018-11-21 | Covidien LP | Controlled fracture connections for stents |
| US7291166B2 (en) | 2005-05-18 | 2007-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
| US20060271170A1 (en) | 2005-05-31 | 2006-11-30 | Gale David C | Stent with flexible sections in high strain regions |
| US20110118827A1 (en) | 2005-06-06 | 2011-05-19 | Dr. Tim Wu | Biodegradable stent formed with polymer-bioceramic nanoparticle composite and method of making the same |
| US7622070B2 (en) | 2005-06-20 | 2009-11-24 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing an implantable polymeric medical device |
| US8870940B2 (en) * | 2005-07-25 | 2014-10-28 | Medtronic, Inc. | Endolumenal prosthesis |
| US7658880B2 (en) | 2005-07-29 | 2010-02-09 | Advanced Cardiovascular Systems, Inc. | Polymeric stent polishing method and apparatus |
| US9149378B2 (en) * | 2005-08-02 | 2015-10-06 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
| US9192494B2 (en) * | 2005-08-29 | 2015-11-24 | Advanced Cardiovascular Systems, Inc. | Locking polymer stents |
| US8562666B2 (en) | 2005-09-28 | 2013-10-22 | Nitinol Development Corporation | Intraluminal medical device with nested interlocking segments |
| US7563277B2 (en) | 2005-10-24 | 2009-07-21 | Cook Incorporated | Removable covering for implantable frame projections |
| US20070100431A1 (en) * | 2005-11-03 | 2007-05-03 | Craig Bonsignore | Intraluminal medical device with strain concentrating bridge |
| US8435284B2 (en) * | 2005-12-14 | 2013-05-07 | Boston Scientific Scimed, Inc. | Telescoping bifurcated stent |
| ES2553254T3 (es) | 2005-12-29 | 2015-12-07 | Boehringer Ingelheim Vetmedica, Inc. | Uso de una composición inmunogénica de PCV2 para reducir los síntomas clínicos en cerdos |
| US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
| ATE520425T1 (de) | 2006-02-07 | 2011-09-15 | Tepha Inc | Verstärkte polymilchsäurepolymere und -copolymere |
| WO2007105067A1 (en) | 2006-03-14 | 2007-09-20 | Arterial Remodeling Technologies, S.A. | Method of monitoring positioning of polymeric stents |
| WO2007109621A2 (en) * | 2006-03-20 | 2007-09-27 | Xtent, Inc. | Apparatus and methods for deployment of linked prosthetic segments |
| WO2007112064A2 (en) | 2006-03-24 | 2007-10-04 | Prescient Medical Inc | Conformable vascular prosthesis delivery system |
| US8652192B2 (en) | 2006-03-31 | 2014-02-18 | St. Jude Medical, Cardiology Division, Inc. | Stent and system and method for deploying a stent |
| US7964210B2 (en) | 2006-03-31 | 2011-06-21 | Abbott Cardiovascular Systems Inc. | Degradable polymeric implantable medical devices with a continuous phase and discrete phase |
| ES2381701T3 (es) | 2006-04-12 | 2012-05-30 | Arterial Remodeling Technologies S.A. | Métodos mejorados de alisado y pulido de la superficie de stents poliméricos para reducir los sitios biológicamente activos |
| US20130190676A1 (en) | 2006-04-20 | 2013-07-25 | Limflow Gmbh | Devices and methods for fluid flow through body passages |
| US8003156B2 (en) | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
| US7594928B2 (en) | 2006-05-17 | 2009-09-29 | Boston Scientific Scimed, Inc. | Bioabsorbable stents with reinforced filaments |
| US7761968B2 (en) | 2006-05-25 | 2010-07-27 | Advanced Cardiovascular Systems, Inc. | Method of crimping a polymeric stent |
| US20070282434A1 (en) | 2006-05-30 | 2007-12-06 | Yunbing Wang | Copolymer-bioceramic composite implantable medical devices |
| US8343530B2 (en) | 2006-05-30 | 2013-01-01 | Abbott Cardiovascular Systems Inc. | Polymer-and polymer blend-bioceramic composite implantable medical devices |
| US7959940B2 (en) | 2006-05-30 | 2011-06-14 | Advanced Cardiovascular Systems, Inc. | Polymer-bioceramic composite implantable medical devices |
| US7842737B2 (en) | 2006-09-29 | 2010-11-30 | Abbott Cardiovascular Systems Inc. | Polymer blend-bioceramic composite implantable medical devices |
| US20070281117A1 (en) | 2006-06-02 | 2007-12-06 | Xtent, Inc. | Use of plasma in formation of biodegradable stent coating |
| US20070286941A1 (en) | 2006-06-13 | 2007-12-13 | Bin Huang | Surface treatment of a polymeric stent |
| US8535372B1 (en) | 2006-06-16 | 2013-09-17 | Abbott Cardiovascular Systems Inc. | Bioabsorbable stent with prohealing layer |
| US20070290412A1 (en) | 2006-06-19 | 2007-12-20 | John Capek | Fabricating a stent with selected properties in the radial and axial directions |
| WO2008002441A2 (en) | 2006-06-23 | 2008-01-03 | Boston Scientific Limited | Bifurcated stent with twisted hinges |
| US9072820B2 (en) | 2006-06-26 | 2015-07-07 | Advanced Cardiovascular Systems, Inc. | Polymer composite stent with polymer particles |
| US20080001330A1 (en) | 2006-06-28 | 2008-01-03 | Bin Huang | Fabricating polymer stents with injection molding |
| US7740791B2 (en) | 2006-06-30 | 2010-06-22 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a stent with features by blow molding |
| US20080077231A1 (en) | 2006-07-06 | 2008-03-27 | Prescient Medical, Inc. | Expandable vascular endoluminal prostheses |
| AU2007273119A1 (en) | 2006-07-07 | 2008-01-17 | Surmodics, Inc. | Implantable medical articles having pro-healing coatings |
| GB0613670D0 (en) * | 2006-07-10 | 2006-08-16 | Angiomed Ag | Tubular metal prosthesis and method of making it |
| US9089627B2 (en) | 2006-07-11 | 2015-07-28 | Abbott Cardiovascular Systems Inc. | Stent fabricated from polymer composite toughened by a dispersed phase |
| US7794495B2 (en) | 2006-07-17 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Controlled degradation of stents |
| US8460364B2 (en) * | 2006-07-20 | 2013-06-11 | Orbusneich Medical, Inc. | Bioabsorbable polymeric medical device |
| US9265866B2 (en) | 2006-08-01 | 2016-02-23 | Abbott Cardiovascular Systems Inc. | Composite polymeric and metallic stent with radiopacity |
| US8016879B2 (en) | 2006-08-01 | 2011-09-13 | Abbott Cardiovascular Systems Inc. | Drug delivery after biodegradation of the stent scaffolding |
| US20080033540A1 (en) | 2006-08-01 | 2008-02-07 | Yunbing Wang | Methods to prepare polymer blend implantable medical devices |
| CA2659761A1 (en) | 2006-08-02 | 2008-02-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
| US8062465B1 (en) | 2006-08-02 | 2011-11-22 | Abbott Cardiovascular Systems Inc. | Methods for improved stent retention |
| US7923022B2 (en) | 2006-09-13 | 2011-04-12 | Advanced Cardiovascular Systems, Inc. | Degradable polymeric implantable medical devices with continuous phase and discrete phase |
| JP2010503494A (ja) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | 生分解性内部人工器官およびその製造方法 |
| EP2076211A4 (en) | 2006-10-20 | 2015-07-22 | Elixir Medical Corp | LUMINOUS PROSTHESES AND METHODS OF COATING THEREOF |
| EP2094204B1 (en) | 2006-10-21 | 2020-01-08 | CeloNova Stent, Inc. | Deformable lumen support devices |
| US20080097580A1 (en) | 2006-10-23 | 2008-04-24 | Vipul Bhupendra Dave | Morphological structures for polymeric drug delivery devices |
| WO2008084286A2 (en) | 2006-10-25 | 2008-07-17 | Arterial Remodeling Technologies, S.A. | Method for expansion and deployment of polymeric structures including stents |
| US20080103584A1 (en) | 2006-10-25 | 2008-05-01 | Biosensors International Group | Temporal Intraluminal Stent, Methods of Making and Using |
| US9192471B2 (en) | 2007-01-08 | 2015-11-24 | Millipede, Inc. | Device for translumenal reshaping of a mitral valve annulus |
| FR2911063B1 (fr) | 2007-01-09 | 2009-03-20 | Stentys S A S Soc Par Actions | Structure de pont ruptible pour un stent, et stent incluant de telles structures de pont. |
| CN100586520C (zh) | 2007-01-18 | 2010-02-03 | 赖英光 | 组合式滑梯与爬梯 |
| US20080177373A1 (en) | 2007-01-19 | 2008-07-24 | Elixir Medical Corporation | Endoprosthesis structures having supporting features |
| US20160213499A1 (en) * | 2007-01-19 | 2016-07-28 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
| US8814930B2 (en) | 2007-01-19 | 2014-08-26 | Elixir Medical Corporation | Biodegradable endoprosthesis and methods for their fabrication |
| US20150374521A1 (en) | 2008-01-17 | 2015-12-31 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
| US20130150943A1 (en) | 2007-01-19 | 2013-06-13 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
| US7704275B2 (en) * | 2007-01-26 | 2010-04-27 | Reva Medical, Inc. | Circumferentially nested expandable device |
| EP1958598A1 (de) | 2007-02-16 | 2008-08-20 | Universität Zürich | Wachstumsfähige, rohrförmige Stützprothese |
| US20080249608A1 (en) | 2007-04-04 | 2008-10-09 | Vipul Dave | Bioabsorbable Polymer, Bioabsorbable Composite Stents |
| US8002817B2 (en) | 2007-05-04 | 2011-08-23 | Abbott Cardiovascular Systems Inc. | Stents with high radial strength and methods of manufacturing same |
| US8128679B2 (en) | 2007-05-23 | 2012-03-06 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
| US7829008B2 (en) | 2007-05-30 | 2010-11-09 | Abbott Cardiovascular Systems Inc. | Fabricating a stent from a blow molded tube |
| US8328867B2 (en) | 2007-06-08 | 2012-12-11 | Medtronic Vascular, Inc. | Drug loaded implantable medical device |
| WO2009002819A2 (en) * | 2007-06-22 | 2008-12-31 | Cr Bard Inc. | Locked segments pushable stent-graft |
| US7666342B2 (en) | 2007-06-29 | 2010-02-23 | Abbott Cardiovascular Systems Inc. | Method of manufacturing a stent from a polymer tube |
| US20110130822A1 (en) * | 2007-07-20 | 2011-06-02 | Orbusneich Medical, Inc. | Bioabsorbable Polymeric Compositions and Medical Devices |
| DE102007034364A1 (de) | 2007-07-24 | 2009-01-29 | Biotronik Vi Patent Ag | Degradierbarer Metallstent mit wirkstoffhaltiger Beschichtung |
| US9566178B2 (en) * | 2010-06-24 | 2017-02-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
| US7988723B2 (en) * | 2007-08-02 | 2011-08-02 | Flexible Stenting Solutions, Inc. | Flexible stent |
| JP2010535541A (ja) | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | 広い表面積を有する医療器具用のコーティング |
| US20090076584A1 (en) * | 2007-09-19 | 2009-03-19 | Xtent, Inc. | Apparatus and methods for deployment of multiple custom-length prostheses |
| EP2186492B1 (en) * | 2007-09-27 | 2012-08-15 | Terumo Kabushiki Kaisha | Stent and living organ dilator |
| US8709071B1 (en) | 2007-09-28 | 2014-04-29 | Abbott Cardiovascular Systems Inc. | Stent with preferential coating |
| US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
| US20090111787A1 (en) | 2007-10-31 | 2009-04-30 | Florencia Lim | Polymer blends for drug delivery stent matrix with improved thermal stability |
| US7824601B1 (en) | 2007-11-14 | 2010-11-02 | Abbott Cardiovascular Systems Inc. | Process of making a tubular implantable medical device |
| JP2011504780A (ja) * | 2007-11-28 | 2011-02-17 | ザ・プロヴォスト,フェローズ・アンド・スカラーズ・オブ・ザ・カレッジ・オブ・ザ・ホーリー・アンド・アンディヴァイデッド・トリニティー・オブ・クイーン・エリザベス,ニア・ダブリン | 管腔人工器官 |
| EP2211773A4 (en) * | 2007-11-30 | 2015-07-29 | Reva Medical Inc | AXIAL-RADIAL NESTED EXPANDABLE DEVICE |
| US20090234429A1 (en) * | 2008-02-07 | 2009-09-17 | Lilip Lau | Self-restraining endoluminal prosthesis |
| US9004182B2 (en) * | 2008-02-15 | 2015-04-14 | Baker Hughes Incorporated | Expandable downhole actuator, method of making and method of actuating |
| US8414638B2 (en) * | 2008-03-12 | 2013-04-09 | Abbott Cardiovascular Systems Inc. | Method for fabricating a polymer stent with break-away links for enhanced stent retenton |
| US8252215B2 (en) | 2008-03-31 | 2012-08-28 | Abbott Cardiovascular Systems Inc. | Method for fabricating a stent with nucleating agent |
| US20110152997A1 (en) * | 2008-06-05 | 2011-06-23 | Daniel John Kelly | Delivery system for multiple stents |
| EP2296578A4 (en) | 2008-06-12 | 2014-01-15 | Elixir Medical Corp | INTRAVASCULAR STENT |
| US8765040B2 (en) | 2008-08-11 | 2014-07-01 | Abbott Cardiovascular Systems Inc. | Medical device fabrication process including strain induced crystallization with enhanced crystallization |
| US8372332B2 (en) | 2008-08-11 | 2013-02-12 | Abbott Cardiovascular Systems Inc. | Fabricating an implantable medical device from an amorphous or very low crystallinity polymer construct |
| US20110260352A1 (en) | 2010-04-21 | 2011-10-27 | Fuh-Wei Tang | Stabilizing Semi-Crystalline Polymers To Improve Storage Performance Of Medical Devices |
| US8394317B2 (en) | 2008-08-11 | 2013-03-12 | Abbott Cardiovascular Systems Inc. | Method of improving fracture toughness of implantable medical devices through annealing |
| US8337739B2 (en) | 2008-08-12 | 2012-12-25 | Abbott Cardiovascular Systems Inc. | Improving fracture toughness of medical devices with a stereocomplex nucleating agent |
| DE102008038367A1 (de) | 2008-08-19 | 2010-02-25 | Biotronik Vi Patent Ag | Stent und Verfahren und Vorrichtung zur Herstellung des Stents |
| EP2355755B1 (en) | 2008-09-15 | 2017-10-18 | Abbott Laboratories Vascular Enterprises Limited | Stent with independent stent rings and transitional attachments |
| JP5559798B2 (ja) * | 2008-10-10 | 2014-07-23 | レヴァ メディカル、 インコーポレイテッド | 拡張可能スライドとロックステント |
| US9572692B2 (en) | 2009-02-02 | 2017-02-21 | Abbott Cardiovascular Systems Inc. | Bioabsorbable stent that modulates plaque geometric morphology and chemical composition |
| WO2010091093A1 (en) | 2009-02-03 | 2010-08-12 | Abbott Cardiovascular Systems Inc. | Improved laser cutting process for forming stents |
| US20100217370A1 (en) | 2009-02-20 | 2010-08-26 | Boston Scientific Scimed, Inc. | Bioerodible Endoprosthesis |
| US8435281B2 (en) | 2009-04-10 | 2013-05-07 | Boston Scientific Scimed, Inc. | Bioerodible, implantable medical devices incorporating supersaturated magnesium alloys |
| US9492587B2 (en) | 2009-04-13 | 2016-11-15 | Abbott Cardiovascular Systems Inc. | Stent made from an ultra high molecular weight bioabsorbable polymer with high fatigue and fracture resistance |
| ES2968361T3 (es) | 2009-05-20 | 2024-05-09 | Lyra Therapeutics Inc | Un método para elaborar un implante autoexpandible |
| US8119704B2 (en) | 2009-07-21 | 2012-02-21 | Abbott Cardiovascular Systems Inc. | Implantable medical device comprising copolymer of L-lactide with improved fracture toughness |
| EP2470119B1 (en) | 2009-08-27 | 2017-05-10 | Medtronic Inc. | Transcatheter valve delivery systems |
| DE202009012562U1 (de) * | 2009-09-16 | 2009-12-17 | Bentley Surgical Gmbh | Stent mit Dehnelementen |
| US8425587B2 (en) * | 2009-09-17 | 2013-04-23 | Abbott Cardiovascular Systems Inc. | Method of treatment with a bioabsorbable stent with time dependent structure and properties and regio-selective degradation |
| US8562670B2 (en) | 2010-04-01 | 2013-10-22 | Abbott Cardiovascular Systems Inc. | Implantable prosthesis with depot retention feature |
| US8613880B2 (en) | 2010-04-21 | 2013-12-24 | Abbott Cardiovascular Systems Inc. | Post electron beam conditioning of polymeric medical devices |
| WO2012035550A2 (en) * | 2010-09-13 | 2012-03-22 | Meril Life Sciences Pvt Ltd. | Stents with low strut thickness and variable strut geometry |
| US9345602B2 (en) | 2010-09-23 | 2016-05-24 | Abbott Cardiovascular Systems Inc. | Processes for making crush recoverable polymer scaffolds |
| WO2012054166A1 (en) | 2010-10-18 | 2012-04-26 | Boston Scientific Scimed, Inc. | Medical implant including a magnesium-based tie layer |
| US20120191177A1 (en) * | 2011-01-20 | 2012-07-26 | Medtronic Vascular, Inc. | Tubular Helical Stent With Rotatable Connections and Method of Making |
| US9220615B2 (en) * | 2011-02-23 | 2015-12-29 | Celonova Stent, Inc. | Stent having at least one connecting member configured to controllably sever in vivo |
| DE202011003403U1 (de) * | 2011-03-01 | 2011-05-19 | Osypka Ag, 79618 | Gefäßstütze mit Sollbruchstelle |
| US8709070B2 (en) | 2011-05-10 | 2014-04-29 | Abbott Cardiovascular Systems Inc. | Bioabsorbable scaffold with particles providing delayed acceleration of degradation |
| US8834776B2 (en) | 2011-05-10 | 2014-09-16 | Abbott Cardiovascular Systems Inc. | Control of degradation profile of bioabsorbable poly(l-lactide) scaffold |
| US8545546B2 (en) | 2011-05-13 | 2013-10-01 | Abbott Cardiovascular Systems Inc. | Bioabsorbable scaffolds made from composites |
| WO2013003644A1 (en) * | 2011-06-30 | 2013-01-03 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
| US20130085564A1 (en) | 2011-10-03 | 2013-04-04 | Abbott Cardiovascular Systems Inc. | Modified scaffolds for peripheral applications |
| DE202012002340U1 (de) | 2012-03-03 | 2012-04-16 | Peter Osypka | Gefäßstütze hoher Flexibilität mit Sollbruchstelle |
| US9498359B2 (en) | 2012-07-13 | 2016-11-22 | Abbott Cardiovascular Systems Inc. | Polymer scaffolds for peripheral vessels |
| US8968387B2 (en) | 2012-07-23 | 2015-03-03 | Abbott Cardiovascular Systems Inc. | Shape memory bioresorbable polymer peripheral scaffolds |
| US8834556B2 (en) | 2012-08-13 | 2014-09-16 | Abbott Cardiovascular Systems Inc. | Segmented scaffold designs |
| KR101231197B1 (ko) | 2012-09-20 | 2013-02-07 | 썬텍 주식회사 | 고분자 스텐트 |
| GB2512016A (en) | 2012-09-24 | 2014-09-24 | Arterius Ltd | Methods |
| US9956097B2 (en) | 2012-10-23 | 2018-05-01 | Abbott Cardiovascular Systems Inc. | Methods for vascular restoration therapy |
| WO2014091438A2 (en) | 2012-12-12 | 2014-06-19 | Shalya Medical Technologies, (India) Pvt. Ltd | An improved bioresorbable polymeric vascular stent device |
| US9655756B2 (en) * | 2012-12-21 | 2017-05-23 | Cook Medical Technologies Llc | Systems and methods for deploying a portion of a stent using an auger-style device |
| EP2799036A1 (de) * | 2013-04-02 | 2014-11-05 | Biotronik AG | Intraluminale Endoprothese und Verfahren zur Herstellung desselbe |
| US10039656B2 (en) * | 2013-06-05 | 2018-08-07 | Abbott Cardiovascular Systems Inc. | Coupled scaffold segments |
| US10143572B2 (en) | 2013-09-04 | 2018-12-04 | Abbott Cardiovascular Systems Inc. | Assessment of a drug eluting bioresorbable vascular scaffold |
| CN105578995B (zh) * | 2013-09-27 | 2018-05-18 | 泰尔茂株式会社 | 支架 |
| JP6632143B2 (ja) * | 2014-07-04 | 2020-01-15 | 国立大学法人山口大学 | ラチェット付きポリマーステント |
| US9180005B1 (en) | 2014-07-17 | 2015-11-10 | Millipede, Inc. | Adjustable endolumenal mitral valve ring |
| US9259339B1 (en) | 2014-08-15 | 2016-02-16 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
| US9855156B2 (en) | 2014-08-15 | 2018-01-02 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
| US9480588B2 (en) | 2014-08-15 | 2016-11-01 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
| US9730819B2 (en) | 2014-08-15 | 2017-08-15 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
| WO2016136375A1 (ja) * | 2015-02-27 | 2016-09-01 | テルモ株式会社 | ステントおよびステントの製造方法 |
| JP2017164323A (ja) * | 2016-03-16 | 2017-09-21 | テルモ株式会社 | ステント |
| EP3861961B1 (en) * | 2016-05-16 | 2025-11-12 | Elixir Medical Corporation | Uncaging stent |
| JP2018046934A (ja) * | 2016-09-20 | 2018-03-29 | テルモ株式会社 | ステント |
| CN111212617B (zh) | 2017-08-11 | 2022-06-03 | 万能医药公司 | 撑开支架 |
-
2017
- 2017-05-15 EP EP21150336.2A patent/EP3861961B1/en active Active
- 2017-05-15 ES ES17799967T patent/ES2873887T3/es active Active
- 2017-05-15 CN CN202110387479.9A patent/CN113143536B/zh active Active
- 2017-05-15 WO PCT/US2017/032748 patent/WO2017200956A1/en not_active Ceased
- 2017-05-15 JP JP2018560073A patent/JP6963566B2/ja active Active
- 2017-05-15 CN CN201780044210.2A patent/CN109561955B/zh active Active
- 2017-05-15 EP EP17799967.9A patent/EP3457985B1/en active Active
- 2017-05-25 US US15/605,601 patent/US9943426B2/en active Active
-
2018
- 2018-03-14 US US15/921,508 patent/US10076431B2/en active Active
- 2018-07-18 US US16/039,194 patent/US10271976B2/en active Active
-
2019
- 2019-03-18 US US16/356,933 patent/US10383750B1/en active Active
- 2019-07-22 US US16/518,657 patent/US10786374B2/en active Active
-
2021
- 2021-03-12 JP JP2021039952A patent/JP7478110B2/ja active Active
- 2021-11-02 JP JP2021179301A patent/JP7029019B2/ja active Active
-
2022
- 2022-03-28 JP JP2022051468A patent/JP7586848B2/ja active Active
-
2023
- 2023-09-29 JP JP2023169649A patent/JP2023165987A/ja active Pending
-
2025
- 2025-01-28 JP JP2025011857A patent/JP2025062612A/ja active Pending
- 2025-08-25 JP JP2025139627A patent/JP2025172814A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113143536B (zh) | 2022-08-30 |
| US10383750B1 (en) | 2019-08-20 |
| US9943426B2 (en) | 2018-04-17 |
| JP7586848B2 (ja) | 2024-11-19 |
| JP7478110B2 (ja) | 2024-05-02 |
| JP2025172814A (ja) | 2025-11-26 |
| ES2873887T3 (es) | 2021-11-04 |
| JP2022076014A (ja) | 2022-05-18 |
| US20190231564A1 (en) | 2019-08-01 |
| EP3457985A4 (en) | 2020-01-22 |
| CN109561955B (zh) | 2021-04-16 |
| US10271976B2 (en) | 2019-04-30 |
| US10076431B2 (en) | 2018-09-18 |
| EP3861961A1 (en) | 2021-08-11 |
| CN113143536A (zh) | 2021-07-23 |
| JP7029019B2 (ja) | 2022-03-02 |
| US20180200091A1 (en) | 2018-07-19 |
| WO2017200956A1 (en) | 2017-11-23 |
| EP3861961B1 (en) | 2025-11-12 |
| EP3457985A1 (en) | 2019-03-27 |
| JP2025062612A (ja) | 2025-04-14 |
| US20170290686A1 (en) | 2017-10-12 |
| US20190365548A1 (en) | 2019-12-05 |
| CN109561955A (zh) | 2019-04-02 |
| JP2022017452A (ja) | 2022-01-25 |
| US10786374B2 (en) | 2020-09-29 |
| US20180318113A1 (en) | 2018-11-08 |
| EP3457985B1 (en) | 2021-02-17 |
| JP2021087886A (ja) | 2021-06-10 |
| JP2023165987A (ja) | 2023-11-17 |
| JP2019520116A (ja) | 2019-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7029019B2 (ja) | アンケージングステント | |
| CN111212617B (zh) | 撑开支架 | |
| US12011378B2 (en) | Uncaging stent | |
| US20230201014A1 (en) | Uncaging stent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190204 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190325 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200512 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200512 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201008 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20201008 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20201207 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201217 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210519 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210707 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20210707 |
|
| C876 | Explanation why request for accelerated appeal examination is justified |
Free format text: JAPANESE INTERMEDIATE CODE: C876 Effective date: 20210707 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20210716 |
|
| C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20210719 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20210806 |
|
| C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20210811 |
|
| C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20210824 |
|
| C23 | Notice of termination of proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C23 Effective date: 20210909 |
|
| C305 | Report on accelerated appeal examination |
Free format text: JAPANESE INTERMEDIATE CODE: C305 Effective date: 20210929 |
|
| C03 | Trial/appeal decision taken |
Free format text: JAPANESE INTERMEDIATE CODE: C03 Effective date: 20211014 |
|
| C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20211014 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211015 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6963566 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |